Pharma · Clinical Trial Acceleration

Hit enrollment, data-lock, and submission milestones with zero critical findings.

Frequently asked questions

What does the Pharma · Clinical Trial Acceleration blueprint do?

Hit enrollment, data-lock, and submission milestones with zero critical findings.

What KPIs does the Pharma blueprint target?

Median Site Activation from 120 to ≤ 84 (monthly). LPLV → Lock from 45 to ≤ 21 (quarterly).

How long does the Pharma · Clinical Trial Acceleration deployment take?

16 weeks.

What systems does the Pharma blueprint integrate with?

Integrates with Veeva Vault eTMF, Medidata Rave EDC, Salesforce Health Cloud, Slack through the AEROSS Execution Mesh. All writes are credit-metered, CAPS-gated, and audit-stamped.

What regulatory requirements does this blueprint address?

ICH E6(R3) GCP; 21 CFR Part 11 audit trails; IRB/EC approval cadence All agent actions inherit AEROSS CAPS governance — autonomy ceilings, human approval gates, and a tamper-evident audit log.